Stocks and Investing Stocks and Investing
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018

David Lewis Maintained (ZBH) at Buy with Decreased Target to $148 on, Feb 26th, 2018


Published on 2024-10-26 03:20:28 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $150 to $148 on, Feb 26th, 2018.

David has made no other calls on ZBH in the last 4 months.



There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Isaac Ro of "Goldman Sachs" Upgraded from Strong Sell to Hold on, Wednesday, December 20th, 2017
  • Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold on, Thursday, November 2nd, 2017


These are the ratings of the 4 analyists that currently disagree with David


  • Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Wednesday, January 31st, 2018
  • Rick Wise of "Stifel" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Kristen Stewart of "Deutsche Bank" Upgraded from Hold to Strong Buy on, Tuesday, November 14th, 2017
  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Decreased Target to $135 on, Thursday, November 2nd, 2017
Contributing Sources